Drug Profile
Prostaglandin E1 nanoparticle - LTT Bio-Pharma
Alternative Names: Lipo-PGE1; LT 2003 - LTT Bio Pharma; LT-0101; Nano prostaglandin E1; Nano-PGE1Latest Information Update: 10 Apr 2024
Price :
$50
*
At a glance
- Originator LTT Bio-Pharma
- Developer Beijing Tide Pharmaceutical; LTT Bio-Pharma
- Class Prostaglandins
- Mechanism of Action Prostaglandin E1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Arterial occlusive disorders
- No development reported Intermittent claudication; Spinal stenosis
Most Recent Events
- 05 Apr 2024 Preclinical trials in Arterial occlusive disorders in Japan (IV) prior to April 2024 (LTT Bio-Pharma pipeline, April 2024)
- 28 Oct 2019 No recent reports of development identified for research development in Intermittent-claudication in Japan (IV)
- 28 Feb 2019 No recent reports of development identified for research development in Spinal-stenosis in Japan (IV)